請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/49694
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 王儷穎(Li-Ying Wang) | |
dc.contributor.author | Yi-Hsuan Huang | en |
dc.contributor.author | 黃怡璇 | zh_TW |
dc.date.accessioned | 2021-06-15T11:42:26Z | - |
dc.date.available | 2019-08-26 | |
dc.date.copyright | 2016-08-26 | |
dc.date.issued | 2016 | |
dc.date.submitted | 2016-08-15 | |
dc.identifier.citation | 1. 行政院衛生福利部國民健康署。民國103年主要死因統計結果分析。臺灣;2015。
2. Shridhar R, Imani-Shikhabadi R, Davis B, Streeter O, Thomas C, Jr. Curative treatment of esophageal cancer: an evidenced based review. J Gastrointest Cancer 2013;44:375-84. 3. Stahl M, Mariette C, Haustermans K, Cervantes A, Arnold D. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24 Suppl 6:51-6. 4. Morota M, Gomi K, Kozuka T, Chin K, Matsuura M, Oguchi M, et al. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 2009;75:122-8. 5. Haj Mohammad N, Hulshof MC, Bergman JJ, Geijsen D, Wilmink JW, van Berge Henegouwen MI, et al. Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma. BMC Cancer 2014;14:56-61. 6. Kaur P, Hurwitz MD, Krishnan S, Asea A. Combined hyperthermia and radiotherapy for the treatment of cancer. Cancers (Basel) 2011;3:3799-823. 7. Purdy JA. Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques. Health Phys 2008;95:666-76. 8. Hsieh CH, Lin YC, Chen YJ, Wu HD, Wang LY. Diaphragm contractile dysfunction causes by off-target low-dose irradiation. Am J Transl Res 2016;8:1510-7. 9. Singer J, Yelin EH, Katz PP, Sanchez G, Iribarren C, Eisner MD, et al. Respiratory and skeletal muscle strength in chronic obstructive pulmonary disease: impact on exercise capacity and lower extremity function. J Cardiopulm Rehabil Prev 2011;31:111-9. 10. Avendano CE, Flume PA, Silvestri GA, King LB, Reed CE. Pulmonary complications after esophagectomy. Ann Thorac Surg 2002;73:922-6. 11. Bosch DJ, Muijs CT, Mul VE, Beukema JC, Hospers GA, Burgerhof JG, et al. Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients. Ann Surg Oncol 2014;21:605-11. 12. Abou-Jawde RM, Mekhail T, Adelstein DJ, Rybicki LA, Mazzone PJ, Caroll MA, et al. Impact of induction concurrent chemoradiotherapy on pulmonary function and postoperative acute respiratory complications in esophageal cancer. Chest 2005;128:250-5. 13. Hsu FM, Lee YC, Lee JM, Hsu CH, Lin CC, Tsai YC, et al. Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy. Ann Surg Oncol 2009;16:1669-77. 14. Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J 2011;37:416-25. 15. 楊佩瑜。以動物模式探討阻力呼吸訓練對降低放射照射引起之橫膈肌收縮功能異常之成效。臺灣大學物理治療學系暨研究所。碩士論文;2014。 16. Esophageal cancer-estimated incidence, mortality and prevalence worldwide in 2012, 2014 17. Law S, Wong J. Changing disease burden and management issues for esophageal cancer in the Asia-Pacific region. J Gastroenterol Hepatol 2002;17:374-81. 18. Cotton RG, Langer R, Leong T, Martinek J, Sewram V, Smithers M, et al. Coping with esophageal cancer approaches worldwide. Ann N Y Acad Sci 2014;1325:138-58. 19. Compton C, Byrd D, Garcia-Aguilar J, Kurtzman S, Olawaiye A, Washington M. Esophagus and esophagogastric junction. In: Compton CC, Byrd DR, Garcia-Aguilar J, Kurtzman SH, Olawaiye A, Washington MK, eds. AJCC Cancer Staging Atlas: Springer New York, 2012; 129-41. 20. Rice TW, Rusch VW, Ishwaran H, Blackstone EH. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals. Cancer 2010;116:3763-73. 21. Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, et al. Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw 2011;9:830-87. 22. Bus P, Lemmens VE, Van Oijen MG, Creemers GJ, Nieuwenhuijzen GA, Van Baal JW, et al. Prognostic factors for medium- and long-term survival of esophageal cancer patients in the Netherlands. J Surg Oncol 2014;109:465-71. 23. Hamai Y, Hihara J, Taomoto J, Yamakita I, Ibuki Y, Okada M. Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer. Dis Esophagus 2015;28:358-64. 24. Rice T. Staging of esophageal cancer: TNM and beyond. Esophagus 2010;7:189-95. 25. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29. 26. Andreollo NA, Tercioti Jr V, Lopes LR, de Souza Coelho-Neto J. Neoadjuvant chemoradiotherapy and surgery compared with surgery alone in squamous cell carcinoma of the esophagus. Arq Gastroenterol 2013;50:101-6. 27. Battaglini CL, Hackney AC, Goodwin ML. Cancer cachexia: muscle physiology and exercise training. Cancers (Basel) 2012;4:1247-51. 28. Wu J, Huang C, Xiao H, Tang Q, Cai W. Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer. Nutrition 2013;29:1310-4. 29. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011;12:489-95. 30. Roberts BM, Ahn B, Smuder AJ, Al-Rajhi M, Gill LC, Beharry AW, et al. Diaphragm and ventilatory dysfunction during cancer cachexia. FASEB J 2013;27:2600-10. 31. Ilson DH. Esophageal cancer chemotherapy: recent advances. Gastrointest Cancer Res 2008;2:85-92. 32. Christensen DM, Livingston GK, Sugarman SL, Parillo SJ, Glassman ES. Management of ionizing radiation injuries and illnesses, Part 3: Radiobiology and health effects of ionizing radiation. J Am Osteopath Assoc 2014;114:556-65. 33. Ask A, Albertsson M, Jarhult J, Cavallin-Stahl E. A systematic overview of radiation therapy effects in oesophageal cancer. Acta Oncol 2003;42:462-75. 34. Jentzsch K, Binder H, Cramer H, Glaubiger DL, Kessler RM, Bull C, et al. Leg function after radiotherapy for Ewing's sarcoma. Cancer 1981;47:1267-78. 35. Lazarus C. Tongue strength and exercise in healthy individuals and in head and neck cancer patients. Semin Speech Lang 2006;27:260-7. 36. Reynolds JV, Ravi N, Hollywood D, Kennedy MJ, Rowley S, Ryan A, et al. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg 2006;132:549-55. 37. Valkenet K, Trappenburg JC, Gosselink R, Sosef MN, Willms J, Rosman C, et al. Preoperative inspiratory muscle training to prevent postoperative pulmonary complications in patients undergoing esophageal resection (PREPARE study): study protocol for a randomized controlled trial. Trials 2014;15:144. 38. Yoshida N, Watanabe M, Baba Y, Iwagami S, Ishimoto T, Iwatsuki M, et al. Risk factors for pulmonary complications after esophagectomy for esophageal cancer. Surg Today 2014;44:526-32. 39. Murray P, Whiting P, Hutchinson SP, Ackroyd R, Stoddard CJ, Billings C. Preoperative shuttle walking testing and outcome after oesophagogastrectomy. Br J Anaesth 2007;99:809-11. 40. Jones LW, Eves ND, Haykowsky M, Freedland SJ, Mackey JR. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol 2009;10:598-605. 41. Feeney C, Hussey J, Carey M, Reynolds JV. Assessment of physical fitness for esophageal surgery, and targeting interventions to optimize outcomes. Dis Esophagus 2010;23:529-39. 42. Feeney C, Reynolds JV, Hussey J. Preoperative physical activity levels and postoperative pulmonary complications post-esophagectomy. Dis Esophagus 2011;24:489-94. 43. Piccirillo JF, Tierney RM, Costas I, Grove L, Spitznagel, Jr EL. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004;291:2441-7. 44. Koppert LB, Lemmens VE, Coebergh JW, Steyerberg EW, Wijnhoven BP, Tilanus HW, et al. Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer. Br J Surg 2012;99:1693-700. 45. He LR, Qiao W, Liao ZX, Komaki R, Ho L, Hofstetter WL, et al. Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma. BMC Cancer 2015;15:1095. 46. Lv Y, Zhang J, Qiao L. Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy. Mol Clin Oncol 2014;2:870-4. 47. Yamashita H, Omori M, Okuma K, Kobayashi R, Igaki H, Nakagawa K. Longitudinal assessments of quality of life and late toxicities before and after definitive chemoradiation for esophageal cancer. Jpn J Clin Oncol 2014;44:78-84. 48. Scarpa M, Saadeh LM, Fasolo A, Alfieri R, Cagol M, Cavallin F, et al. Health-related quality of life in patients with oesophageal cancer: analysis at different steps of the treatment pathway. J Gastrointest Surg 2013;17:421-33. 49. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002;166:518-624. 50. Shekleton ME. Respiratory muscle conditioning and the work of breathing: a critical balance in the weaning patient. AACN Clin Issues Crit Care Nurs 1991;2:405-14. 51. Goldstein RS. Pulmonary rehabilitation in chronic respiratory insufficiency. 3. Ventilatory muscle training. Thorax 1993;48:1025-33. 52. Bosnak-Guclu M, Gunduz AG, Nazliel B, Irkec C. Comparison of functional exercise capacity, pulmonary function and respiratory muscle strength in patients with multiple sclerosis with different disability levels and healthy controls. J Rehabil Med 2012;44:80-6. 53. England R, Maddocks M, Manderson C, Wilcock A. Factors influencing exercise performance in thoracic cancer. Respir Med 2012;106:294-9. 54. Giua R, Pedone C, Scarlata S, Carrozzo I, Rossi FF, Valiani V, et al. Relationship between respiratory muscle strength and physical performance in elderly hospitalized patients. Rejuvenation Res 2014;17:366-71. 55. Leith DE, Bradley M. Ventilatory muscle strength and endurance training. J Appl Physiol 1976;41:508-16. 56. Bolton CE, Blakey JD, Morgan MD. The British Thoracic Society guideline on pulmonary rehabilitation in adults: your opinion is noted. Thorax 2014;69:388-9. 57. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013;188:e13-64. 58. Eastwood PR, Hillman DR. A threshold loading device for testing of inspiratory muscle performance. Eur Respir J 1995;8:463-6. 59. Hill K, Cecins NM, Eastwood PR, Jenkins SC. Inspiratory muscle training for patients with chronic obstructive pulmonary disease: a practical guide for clinicians. Arch Phys Med Rehabil 2010;91:1466-70. 60. Klefbeck B, Hamrah Nedjad J. Effect of inspiratory muscle training in patients with multiple sclerosis. Arch Phys Med Rehabil 2003;84:994-9. 61. Fry DK, Pfalzer LA, Chokshi AR, Wagner MT, Jackson ES. Randomized control trial of effects of a 10-week inspiratory muscle training program on measures of pulmonary function in persons with multiple sclerosis. J Neurol Phys Ther 2007;31:162-72. 62. Reyes A, Ziman M, Nosaka K. Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review. Chest 2013;143:1386-94. 63. Montemezzo D, Fregonezi GA, Pereira DA, Britto RR, Reid WD. Influence of inspiratory muscle weakness on inspiratory muscle training responses in chronic heart failure patients: a systematic review and meta-analysis. Arch Phys Med Rehabil 2014;95:1398-407. 64. Ramirez-Sarmiento A, Orozco-Levi M, Guell R, Barreiro E, Hernandez N, Mota S, et al. Inspiratory muscle training in patients with chronic obstructive pulmonary disease: structural adaptation and physiologic outcomes. Am J Respir Crit Care Med 2002;166:1491-7. 65. Hulzebos EH, Helders PJ, Favie NJ, De Bie RA, Brutel de la Riviere A, Van Meeteren NL. Preoperative intensive inspiratory muscle training to prevent postoperative pulmonary complications in high-risk patients undergoing CABG surgery: a randomized clinical trial. JAMA 2006;296:1851-7. 66. Morano MT, Araújo AS, Nascimento FB, da Silva GF, Mesquita R, Pinto JS, et al. Preoperative pulmonary rehabilitation versus chest physical therapy in patients undergoing lung cancer resection: a pilot randomized controlled trial. Arch Phys Med Rehabil 2013;94:53-8. 67. Agrelli TF, de Carvalho Ramos M, Guglielminetti R, Silva AA, Crema E. Preoperative ambulatory inspiratory muscle training in patients undergoing esophagectomy. A pilot study. Int Surg 2012;97:198-202. 68. Dettling DS, van der Schaaf M, Blom RL, Nollet F, Busch OR, van Berge Henegouwen MI. Feasibility and effectiveness of pre-operative inspiratory muscle training in patients undergoing oesophagectomy: a pilot study. Physiother Res Int 2013;18:16-26. 69. van Adrichem EJ, Meulenbroek RL, Plukker JT, Groen H, van Weert E. Comparison of two preoperative inspiratory muscle training programs to prevent pulmonary complications in patients undergoing esophagectomy: a randomized controlled pilot study. Ann Surg Oncol 2014;21:2353-60. 70. Valkenet K, van de Port IG, Dronkers JJ, de Vries WR, Lindeman E, Backx FJ. The effects of preoperative exercise therapy on postoperative outcome: a systematic review. Clin Rehabil 2011;25:99-111. 71. Nomori H, Kobayashi R, Fuyuno G, Morinaga S, Yashima H. Preoperative respiratory muscle training. assessment in thoracic surgery patients with special reference to postoperative pulmonary complications. Chest 1994;105:1782-8. 72. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38. 73. De Troyer A, Borenstein S, Cordier R. Analysis of lung volume restriction in patients with respiratory muscle weakness. Thorax 1980;35:603-10. 74. Kreitzer SM, Saunders NA, Tyler HR, Ingram RH, Jr. Respiratory muscle function in amyotrophic lateral sclerosis. Am Rev Respir Dis 1978;117:437-47. 75. Eastwood PR, Panizza JA, Hillman DR, Finucane KE. Application of a cervical stimulating apparatus for bilateral transcutaneous phrenic nerve stimulation. J Appl Physiol 1995;79:632-7. 76. Preston DC, Shapiro BE. 15 - Basic electromyography: analysis of motor unit action potentials. In: Preston DC, Shapiro BE, eds. Electromyography and Neuromuscular Disorders (Third Edition). London: W.B. Saunders, 2013; 235-48. 77. Preston DC, Shapiro BE. 12 - Basic overview of electromyography. In: Preston DC, Shapiro BE, eds. Electromyography and Neuromuscular Disorders (Third Edition). London: W.B. Saunders, 2013; 125-8. 78. Lindström L, Petersen I. Power spectrum analysis of EMG signals and its applications. In: Desmedt J, ed. Progress in clinical neurophysiology, 1983;1-51. 79. Preston DC, Shapiro BE. 8 - Artifacts and technical factors. In: Preston DC, Shapiro BE, eds. Electromyography and Neuromuscular Disorders (Third Edition). London: W.B. Saunders, 2013; 71-89. 80. Preston DC, Shapiro BE. 14 - Basic electromyography: analysis of spontaneous activity. In: Preston DC, Shapiro BE, eds. Electromyography and Neuromuscular Disorders (Third Edition). London: W.B. Saunders, 2013; 220-34. 81. Bolton CF. Clinical neurophysiology of the respiratory system. Muscle Nerve 1993;16:809-18. 82. Verin E, Straus C, Demoule A, Mialon P, Derenne JP, Similowski T. Validation of improved recording site to measure phrenic conduction from surface electrodes in humans. J Appl Physiol 2002;92:967-74. 83. McKenzie DK, Gandevia SC. Phrenic nerve conduction times and twitch pressures of the human diaphragm. J Appl Physiol 1985;58:1496-504. 84. Renshaw D, Bice MR, Cassidy C, Eldridge JA, Powell DW. A Comparison of Three Computer-based Methods Used to Determine EMG Signal Amplitude. Int J Exerc Sci 2010;3:43-8. 85. Lariviere C, Gagnon D, Gravel D, Bertrand Arsenault A. The assessment of back muscle capacity using intermittent static contractions. Part I - Validity and reliability of electromyographic indices of fatigue. J Electromyogr Kinesiol 2008;18:1006-19. 86. Larivière C, Gravel D, Gagnon D, Arsenault AB. The assessment of back muscle capacity using intermittent static contractions. Part II: Validity and reliability of biomechanical correlates of muscle fatigue. J Electromyogr Kinesiol 2008;18:1020-31. 87. Moxham J, Edwards RH, Aubier M, De Troyer A, Farkas G, Macklem PT, et al. Changes in EMG power spectrum (high-to-low ratio) with force fatigue in humans. J Appl Physiol Respir Environ Exerc Physiol 1982;53:1094-9. 88. Segizbaeva MO, Donina Zh A, Timofeev NN, Korolyov YN, Golubev VN, Aleksandrova NP. EMG analysis of human inspiratory muscle resistance to fatigue during exercise. Adv Exp Med Biol 2013;788:197-205. 89. Walterspacher S, Pietsch F, Walker D, Röcker K, Kabitz H-J. Activation of respiratory muscles during respiratory muscle training. Eur Respir J 2013;42 90. Segizbaeva MO, Timofeev NN, Donina Zh A, Kur'yanovich EN, Aleksandrova NP. Effects of inspiratory muscle training on resistance to fatigue of respiratory muscles during exhaustive exercise. Adv Exp Med Biol 2015;840:35-43. 91. Eleanor Criswell, Cram JR, eds. Cram's introduction to surface electromyography 2nd ed: David Cella, 2011. 92. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34. 93. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7. 94. Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 1994;3:353-64. 95. Chie WC, Tsai CJ, Chiang C, Lee YC. Quality of life of patients with oesophageal cancer in Taiwan: validation and application of the Taiwan Chinese (Mandarin) version of the EORTC QLQ-OES18: a brief communication. Qual Life Res 2010;19:1127-31. 96. Zhao H, Kanda K. Testing psychometric properties of the standard Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30). J Epidemiol 2004;14:193-203. 97. Molassiotis A, Charalambous A, Taylor P, Stamataki Z, Summers Y. The effect of resistance inspiratory muscle training in the management of breathlessness in patients with thoracic malignancies: a feasibility randomised trial. Support Care Cancer 2015;23:1637-45. 98. Gilliam LA, Moylan JS, Callahan LA, Sumandea MP, Reid MB. Doxorubicin causes diaphragm weakness in murine models of cancer chemotherapy. Muscle Nerve 2011;43:94-102. 99. von Dobeln GA, Nilsson M, Adell G, Johnsen G, Hatlevoll I, Tsai J, et al. Pulmonary function and cardiac stress test after multimodality treatment of esophageal cancer. Pract Radiat Oncol 2016;6:e53-9. 100. Cazzola M, MacNee W, Martinez FJ, Rabe KF, Franciosi LG, Barnes PJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J 2008;31:416-69. 101. Tudorache V, Oancea C, Mladinescu OF. Clinical relevance of maximal inspiratory pressure: determination in COPD exacerbation. Int J Chron Obstruct Pulmon Dis 2010;5:119-23. 102. 許玉娟。營養諮商與運動方案對接受放射治療合併化學治療之食道癌病患改善成效之探討。臺灣大學護理學研究所。碩士論文;2013。 103. Tatematsu N, Ezoe Y, Tanaka E, Muto M, Sakai Y, Tsuboyama T. Impact of neoadjuvant chemotherapy on physical fitness, physical activity, and health-related quality of life of patients with resectable esophageal cancer. Am J Clin Oncol 2013;36:53-6. 104. Jung JH, Kim NS. Relative activity of respiratory muscles during prescribed inspiratory muscle training in healthy people. J Phys Ther Sci 2016;28:1046-9. 105. Ramsook AH, Koo R, Molgat-Seon Y, Dominelli PB, Syed N, Ryerson CJ, et al. Diaphragm Recruitment Increases during a Bout of Targeted Inspiratory Muscle Training. Med Sci Sports Exerc 2016;48:1179-86. 106. Moritani T, Muro M, Nagata A. Intramuscular and surface electromyogram changes during muscle fatigue. J Appl Physiol 1986;60:1179-85. 107. Lindley MR, Faghy M, Sowter H, Mickleborough TD. Pilot Study : Can Inspiratory Muscle Training Relieve Symptoms Of Dyspnoea And Improve Quality Of Life For Advanced Cancer Patients? Med Sci Sports Exerc 2016;48:513-4. 108. Tatematsu N, Park M, Tanaka E, Sakai Y, Tsuboyama T. Association between physical activity and postoperative complications after esophagectomy for cancer: a prospective observational study. Asian Pac J Cancer Prev 2013;14:47-51. 109. Nagamatsu Y, Shima I, Yamana H, Fujita H, Shirouzu K, Ishitake T. Preoperative evaluation of cardiopulmonary reserve with the use of expired gas analysis during exercise testing in patients with squamous cell carcinoma of the thoracic esophagus. J Thorac Cardiovasc Surg 2001;121:1064-8. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/49694 | - |
dc.description.abstract | 背景:臺灣食道癌的發病率持續居高不下。同步併用化學放射線治療為最常見的食道癌治療策略,治療對呼吸功能、身體活動功能和生活品質的的影響及吸氣肌訓練的可能性,都是需要進一步探討的課題。目的:本研究之主要目的(一)追蹤評估新診斷原發性食道癌患者進行同步併用化學放射線治療對呼吸功能、身體活動功能和生活品質之影響;及(二)探討治療期間同步進行吸氣肌訓練,對呼吸功能、身體活動功能及生活品質之效益。方法:本研究第一階段共徵招33位受試者,在治療前後,收集受試者之臨床表徵資料並進行呼吸功能(最大呼吸壓測試及肺功能測試)、身體活動功能及生活品質問卷評估。第二階段共徵招6位受試者(對照組及吸氣肌訓練組各3人)。所有測試分別在治療開始前、治療期間每週至治療結束,臨床資料收集及測量項目同第一階段。橫膈肌表面肌電圖評估在最大吸氣壓測試及執行吸氣負荷任務時合併進行。吸氣肌訓練劑量為基線最大吸氣壓之30%(15次/回、3回/天、7天/週),持續至治療結束。以廣義估計方程式(Generalized Estimating Equations, GEE)、線性廣義方程式(Generalized Linear Model, GLM)檢定不同測試時間點在組間及組內之差異,顯著水平標準訂為0.05。結果:第一階段:相較於治療前,受試者之最大吸氣壓、第1秒用力吐氣容積與用力吐氣肺活量皆有顯著下降(p<0.01);身體活動功能及整體生活品質、身體功能、角色功能和疲勞程度也在治療結束後有顯著下降(p<0.01)。第二階段:接受吸氣肌訓練者,其最大吸氣壓、身體活動功能及部分生活品質面向在治療期間均有明顯改善。橫膈肌肌電評估結果顯示訓練後其活化度效率及抗疲勞能力較佳。結論:食道癌患者接受同步併用化學放射線治療會造成呼吸功能、身體活動功能與生活品質下降。與治療同步之吸氣肌訓練具可改善食道癌患者在治療後之呼吸功能(如:橫膈肌肌電活化度及抗疲勞能力)、身體活動功能及生活品質之臨床效益。 | zh_TW |
dc.description.abstract | Background: Incidence rate of esophageal cancer remains high in Taiwan. The impacts of concurrent chemoradiation therapy (CCRT) on respiratory function, physical activity, and quality of life, and the efficacy of inspiratory muscle training (IMT) remains to be determined in patients with esophageal cancer. Purposes: The purposes of this study were to 1) evaluate the effects of CCRT and 2) investigate the effects of synchronous IMT during CCRT on respiratory function, physical activity, and quality of life in patients with newly diagnosed esophageal cancer. Methods: Phase I: a total of 33 subjects were recruited. Clinical data were collected and respiratory function (maximal respiratory pressure and pulmonary function test), physical activity, and quality of life were assessed at baseline and after CCRT was completed. Phase II: a total of 6 subjects were recruited and assigned to either control or IMT group (n=3 per group). Clinical data collection and all measurements were identical to phase I at baseline, and once per week until CCRT was completed. Diaphragmatic surface electromyography was used to exam diaphragm activity during performing maximal inspiratory pressure (MIP) and IMT tasks. Patients in IMT group received IMT with an intensity of 30%MIP, 15 times/set, 3 sets/day for 7 days/week, until CCRT was completed. Generalized Estimating Equations and Generalized Linear Model were used to detect differences of variables between and within groups. Significant level was set at 0.05. Results: Phase I: compared to baseline, respiratory function, physical activity, and quality of life all decreased after CCRT in patients with esophageal cancer (all p<0.01). Phase II: MIP, physical activity and certain aspects of quality of life showed improvement after CCRT in the IMT group. Electromyography showed that diaphragm activation efficiency and fatigability improved after training in the IMT group. Conclusions: CCRT has negative impacts on respiratory function, physical activity, and quality of life in esophageal cancer patients. Synchronous IMT during CCRT showed promising potential to improve respiratory function (e.g., diaphragm function), physical activity, and quality of life in patients with esophageal cancer. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T11:42:26Z (GMT). No. of bitstreams: 1 ntu-105-R02428012-1.pdf: 4020508 bytes, checksum: e80ebdd6581d5de4cc4ee572eb63d303 (MD5) Previous issue date: 2016 | en |
dc.description.tableofcontents | 第一章、前言 1
第一節、研究背景與目的 1 第二節、研究假說 2 第三節、研究重要性 3 第二章、文獻回顧 4 第一節、食道癌症 4 第二節、食道癌症治療與癌症治療相關毒性之影響 5 第三節、吸氣肌訓練 9 第四節、呼吸功能測試 12 第三章、研究方法 17 第一節、研究設計 17 第二節、受試者 17 第三節、實驗流程 17 第四節、研究評估工具與方法 18 第五節、吸氣肌訓練介入方式 21 第六節、研究變項 22 第七節、資料處理與統計分析 23 第四章、研究結果 24 第一節、第一階段實驗結果 24 第二節、第二階段實驗結果 26 第五章、討論 31 第六章、結論 37 參考文獻 38 附錄一 67 附錄二 68 附錄三 69 附錄四 70 附錄五 72 | |
dc.language.iso | zh-TW | |
dc.title | 食道癌患者接受同步併用化學放射線治療對呼吸功能之影響及吸氣肌訓練介入之成效探討 | zh_TW |
dc.title | The effects of concurrent chemoradiation therapy on respiratory function and the efficacy of inspiratory muscle training in patients with esophageal cancer | en |
dc.type | Thesis | |
dc.date.schoolyear | 104-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 吳惠東,陳裕仁,謝忱希,簡盟月 | |
dc.subject.keyword | 食道癌,呼吸功能,橫膈肌表面肌電圖,吸氣肌訓練, | zh_TW |
dc.subject.keyword | Esophageal cancer,Respiratory function,Diaphragmatic surface electromyography,Inspiratory muscle training, | en |
dc.relation.page | 72 | |
dc.identifier.doi | 10.6342/NTU201602303 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2016-08-15 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 物理治療學研究所 | zh_TW |
顯示於系所單位: | 物理治療學系所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-105-1.pdf 目前未授權公開取用 | 3.93 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。